Market closed

Organon/$OGN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Organon

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Ticker

$OGN

Trading on

NYSE

Industry

Pharmaceuticals

Employees

10,000

Organon Metrics

BasicAdvanced
$4.1B
Market cap
3.19
P/E ratio
$5.04
EPS
0.80
Beta
$1.12
Dividend rate
6.96%
Dividend yield
$4.1B
0.8
$23.10
$10.84
2.6M
$1.12
1.705
0.893
1,772.617
6,011.111
22.75%
2.91%
7.91%
-2,710.42%
3.192
0.644
8.41
-0.85
6.389
6.96%
6.96%
4.21%
120.97%
0.50%
-5.48%
58.74%

What the Analysts think about Organon

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Organon stock.

Organon Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Organon Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OGN

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Dec
12
Organon
Dividend·Payment
$0.28
Per share

FAQs

What’s the current market cap for Organon stock?

Organon (OGN) has a market cap of $4.1B as of November 13, 2024.

What is the P/E ratio for Organon stock?

The price to earnings (P/E) ratio for Organon (OGN) stock is 3.19 as of November 13, 2024.

Does Organon stock pay dividends?

Yes, the Organon (OGN) stock pays dividends to shareholders. As of November 13, 2024, the dividend rate is $1.12 and the yield is 6.96%. Organon has a payout ratio of 22.75% on a trailing twelve-month basis.

When is the next Organon dividend payment date?

The next Organon (OGN) dividend payment is scheduled for December 12, 2024.

What is the beta indicator for Organon?

Organon (OGN) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.